Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
The agency is once more accepting pre-submissions for all in vitro diagnostic tests, not just those for COVID-19.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.
It’s beginning to look like Illumina’s roll of the dice is going to come up snake eyes regarding the potential acquisition.
The way the No Surprises Act is implemented would essentially allow private health plans to set out-of-network rates in billing disputes.
Meant to be temporary, remote regulatory assessments proved so successful that the agency will not only continue, but expand their use.
Independent labs accrued a profit of at least $10 on each PCR COVID-19 test performed in the period from May to December 2020, study says.
Some of the lab industry’s biggest players are teaming up to develop new monkeypox diagnostics in response to the current outbreak.
A hostile government policy has done little to slow consolidation of independent medical practices and hospitals.
Now that the finishing touches have been put on LDT-related legislation, what is the likelihood that it will pass?
Two of the biggest merger and acquisition-related deals that came down in May involved BioMérieux and Sema4